HOUSTON - (Jan. 5, 2011) - Zinc ions released at the junction between two neurons (called a synapse) are important signals, but when too much zinc accumulates, cells become dysfunctional or die.
Researchers in the Blue Bird Circle Developmental Neurogenetics Laboratory (http://www.
"These findings pave the way for the development of a new type of neuroprotective medicine for conditions such as seizures, stroke, brain trauma and other neurodegenerative disorders," said Dr. Jeffrey L. Noebels (http://www.
Large amounts of synaptic zinc are found in the hippocampus. However, this brain circuit is a common site for epileptic seizures, and hippocampal cells are extremely vulnerable to damage during a prolonged brain "storm," as seizures are sometimes called. Since seizures activate many other molecules that may potentially injure cells and also are accompanied by a cutoff off of oxygen and glucose to nerves, the contribution of excessive zinc released during the seizure has not been clear.
Zinc finds its way into brain cells through multiple entry sites: ion channels, glutamate receptors, and a family of special uptake transporters known as ZIP proteins. Dr. Jing Qian (http://www.
When he analyzed cellular damage following prolonged seizures in mice that were genetically engineered to be missing the two ZIP genes, he found that a crucial group of hippocampal neurons are remarkably undamaged following even severe seizures lasting six hours or longer.
"This study is exciting, because for the first time we have shown that reducing zinc entry alone, without removing it from the diet or interfering with its other important functions, is an effective way to protect brain cells from damage due to seizures, and probably a variety of other insults to the brain," said Noebels. "We now believe these ZIP proteins represent new and important molecular targets for the development of drugs that can specifically reduce zinc entry and protect memory circuits in the brain from damage."
Others who took part in the research include Kaiping Xu, Jong Yoo, and Tim T. Chen, all of BCM and Glen Andrews of the University of Kansas Medical Center in Kansas City, Kansas.
Funding for this research came from the National Institutes of Neurological Disorders and Stroke and the Blue Bird Circle Pediatric Neurology Research Foundation.
Noebels holds the Cullen Trust for Health Care Endowed Chair.
For more information on basic science research at Baylor College of Medicine, please go to From the Laboratories at Baylor College of Medicine (www.bcm.edu/fromthelab).